Effectiveness of crocin of saffron (Crocus sativus L.) against chemotherapy-induced peripheral neuropathy: A randomized, double-blind, placebo-controlled clinical trial.

doi:10.1016/j.jep.2021.114511

Effectiveness of crocin of saffron (Crocus sativus L.) against chemotherapy-induced peripheral neuropathy: A randomized, double-blind, placebo-controlled clinical trial.

Published Aug 11, 2021 · Hooman Bozorgi, F. Ghahremanfard, Ehsan Motaghi

Journal of ethnopharmacology

Q1 SJR score

16

Citations

1

Influential Citations

Full text

Semantic Scholar

Abstract

Abstract removed due to Elsevier request; this does not indicate any issues with the research. Click the full text link above to read the abstract and view the original source.

RCT

Study Snapshot

Key takeawayCrocin, a constituent of saffron, significantly reduces chemotherapy-induced peripheral neuropathy symptoms in cancer patients, with mild toxicity and adverse effects.

PopulationOlder adults (50-71 years)

Sample size24

MethodsObservational

OutcomesBody Mass Index projections

ResultsSocial networks mitigate obesity in older groups.

·